Share Blog Article Via
<<< EMBIT NEWSLETTER >>>
Healthcare providers treating patients with acute migraine should be aware of an important pharmaceutical update. Eli Lilly has voluntarily discontinued Reyvow® (lasmiditan), a prescription medication approved for the acute treatment of migraine with or without aura in adults.
According to available information, the decision was made for business reasons and is not related to new concerns about the medication’s safety, quality, or effectiveness. While existing inventory may still be available for a limited time, providers should begin planning appropriate treatment transitions for patients currently using Reyvow.
For neurology practices, primary care providers, pain management specialists, and healthcare organizations, this update highlights the importance of proactive patient communication, medication management, and accurate documentation.
>>What Is Reyvow?
Reyvow (lasmiditan) is an FDA-approved prescription medication used for the acute treatment of migraine attacks in adults. It is designed to treat migraine symptoms after they begin and is not intended to prevent future migraine attacks.
The medication became an important option for patients who could not use traditional migraine medications because of certain cardiovascular conditions or other clinical considerations.
>>Why Is Reyvow Being Discontinued?
Healthcare providers may receive questions from patients who have heard about the discontinuation.
Current reports indicate that the manufacturer’s decision was based on commercial and business considerations, not because of newly identified safety risks or reduced effectiveness.
This distinction is important when discussing the change with patients, as many may mistakenly believe the medication has been recalled.
>>What Should Healthcare Providers Do?
Practices caring for migraine patients should review their current medication lists and identify individuals who are actively using Reyvow.
Recommended next steps include:
• Review patients currently prescribed Reyvow.
• Discuss appropriate alternative acute migraine treatment options.
• Update medication records within the EHR.
• Revise treatment plans based on each patient’s clinical needs.
• Notify pharmacy staff and clinical teams of the discontinuation.
• Educate patients not to stop or change medications without consulting their healthcare provider.
Early communication can help prevent treatment interruptions and improve continuity of care.
>>Revenue Cycle and Billing Considerations
Although a medication discontinuation is primarily a clinical issue, it can also affect administrative and revenue cycle processes.
Healthcare organizations should monitor for:
• Prior authorization requests for alternative medications.
• Updates to payer coverage policies.
• Changes in medication documentation.
• Prescription workflow adjustments.
• Accurate diagnosis coding and claim documentation.
• Medication reconciliation during patient visits.
Maintaining complete documentation helps reduce claim denials and supports smoother reimbursement.
>>The Importance of Accurate Documentation
Whenever a patient’s migraine treatment changes, it is essential for healthcare providers to maintain thorough and accurate documentation. Medical records should clearly explain why the medication was discontinued, describe the patient’s current symptoms and clinical condition, and document the provider’s decision-making process when selecting an alternative treatment.
Any newly prescribed medication, follow-up care plan, and counseling provided to the patient should also be recorded in detail. Comprehensive documentation not only supports continuity of care and helps healthcare teams make informed clinical decisions, but it also strengthens coding accuracy, facilitates prior authorizations when needed, and ensures compliance with payer requirements, ultimately reducing the risk of claim denials and reimbursement delays.
>>How Evocare Billings Supports Healthcare Providers
Industry changes like medication discontinuations often create additional administrative work for healthcare practices.
At Evocare Billings & IT Solutions LLC, we help providers stay focused on patient care by supporting the financial side of their practice through:
• Medical Billing and Coding
• Prior Authorization Support
• Insurance Verification
• Claims Submission
• Denial Management
Accounts Receivable Follow-Up
Our experienced team helps healthcare organizations adapt to changing payer requirements while improving reimbursement performance and reducing billing delays.
Final Thoughts
The discontinuation of Reyvow marks an important change in migraine treatment. Although the decision was made for business reasons rather than safety concerns, providers should begin preparing for patient transitions and updating clinical workflows.
Accurate documentation, proactive communication, and efficient revenue cycle management can help ensure patients continue receiving appropriate care while practices maintain operational efficiency.
As healthcare continues to evolve, staying informed about medication updates is essential for delivering quality care and maintaining a healthy revenue cycle.
Need expert support with medical billing, coding, credentialing, or revenue cycle management?
Contact Evocare Billings & IT Solutions LLC today to learn how our experienced team can help your practice improve collections, reduce denials, and streamline billing operations.
Contact us today at info@evocarebillings.com or call (323) 412-5399 to explore how we can help your practice grow with smarter, more efficient billing solutions
Newsletter
Stay updated with industry trends, tips, and smart revenue cycle insights.
Case Study
See how real practices transformed revenue cycles and overcame billing challenges.
Let's get in touch
Please fill up the form, one of our AAPC certified medical biller and coder will reach out to you
